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Background
Individuals suffering from deafness or hearing impair-
ment may experience the same range of mental health
problems as other individuals, but the expression, treat-
ment and outcome of these disorders vary because of dif-
ferences in communication and language use.
Schizophrenia is generally less responsive to antipsychot-
ics in deaf people, requiring higher doses of them and
often combination with mood stabilizing drugs.
Materials and methods
To assess whether adjunctive treatment of valproate (val-
proic acid) to olanzapine can improve the psychotic
symptomatology of a hearing impaired schizophrenic
patient with comorbid atypical anorexia nervosa
The 30-year old female patient presented delusional ideas
of persecution and reference as well as auditory hallucina-
tions and was treated for six weeks with olanzapine (20
mg/day) with a minor therapeutic effect. Thus, a daily
dose of 1000 mg valproic acid was added, since adjunctive
therapy with anticonvulsants (mainly carbamazepine) to
antipsychotics in the treatment of deaf people suffering
from schizophrenia has been reported to have a positive
therapeutic effect.
Results
After three weeks of combination treatment, a substantial
improvement in her psychotic symptomatology was
observed. The treatment was even beneficial, also for her
eating disorder. The patient started gaining weight, and
was willing to try other kinds of food such as meat and
vegetables, not just sweets, milk and cocoa. In the six-
month follow-up after the discharge, she did not demon-
strate any positive psychotic symptoms and she was still
being treated with olanzapine 20 mg/day and valproate
1000 mg/day.
Discussion
The adjunctive use of valproic acid to olanzapine may
have a suitable beneficial effect for the treatment of hear-
ing impaired schizophrenic patients with comorbid eat-
ing disorder.
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